CORRESP Filing
OS Therapies Inc
Date: Aug. 21, 2025 · CIK: 0001795091 · Accession: 0001213900-25-079387
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289443
Letter
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
August 21, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Doris Stacey Gama
Office of Life Sciences
Re: OS Therapies Incorporated Registration Statement on Form S-3 (No. 333-289443)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Monday, August 25, 2025, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
August 21, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Doris Stacey Gama
Office of Life Sciences
Re: OS Therapies Incorporated Registration Statement on Form S-3 (No. 333-289443)
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Monday, August 25, 2025, or as soon as practicable thereafter.
Very truly yours,
OS Therapies Incorporated
Show Raw Text
CORRESP 1 filename1.htm EMAIL: SFeldman@olshanlaw.com DIRECT DIAL: 212.451.2234 August 21, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn.: Doris Stacey Gama Office of Life Sciences Re: OS Therapies Incorporated Registration Statement on Form S-3 (No. 333-289443) Ladies and Gentlemen: On behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Monday, August 25, 2025, or as soon as practicable thereafter. Please advise the undersigned of the effectiveness of the Registration Statement. Very truly yours, /s/ Spencer G. Feldman Spencer G. Feldman cc: Paul A. Romness, MPH August 21, 2025 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn.: Doris Stacey Gama Office of Life Sciences Re: OS Therapies Incorporated Registration Statement on Form S-3 (No. 333-289443) Ladies and Gentlemen: OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Monday, August 25, 2025, or as soon as practicable thereafter. Very truly yours, OS Therapies Incorporated By: /s/ Paul A. Romness Paul A. Romness President and Chief Executive Officer